Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Cyclophosphamide in LGL Leukemia
NCT01976182Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Nov 2013
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, cyclophosphamide in large granular lymphocyte leukemia, sponsored by CHU Rennes. Started Nov 2013; status: completed.
02
Drugs
methotrexatecyclophosphamide
03
Conditions
large granular lymphocyte leukemia
Beyond the preview
Go deeper on NCT01976182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01976182.